|
Subscribe / Renew |
|
|
Contact Us |
|
| ► Subscribe to our Free Weekly Newsletter | |
| home | Welcome, sign in or click here to subscribe. | login |
| |
September 19, 2024
Parse Biosciences, a global life sciences company, hired Kaitie Kramer as vice president of marketing. She will lead the marketing strategy for the company and its portfolio of single cell solutions. Kramer brings more than 20 years of commercial biotech experience to the role and joins Parse from Twist Bioscience, where she served as senior director of commercial marketing, overseeing key initiatives to help drive growth and brand awareness. She also brings extensive single cell and general cell biology experience to the role. While serving as Illumina's first single cell sequencing sales specialist, Kramer was part of the team who helped bring broad awareness to new applications and use cases of single cell sequencing. Previously, she held senior marketing and business development roles with Thermo Fisher Scientific, Illumina, and Irvine Scientific. She holds a bachelor's degree genetics from the University of Wisconsin-Madison. With technology developed at the University of Washington by co-founders Alex Rosenberg and Charles Roco, Parse has raised over $50 million in capital and is now used by 2,000 customers across the world. The company is based in Seattle's South Lake Union district, where it recently expanded into a new headquarters and state-of-the-art laboratory.